CTSB and neoplasm: The HPNP formulation employed in this study has the attribute of being degraded in the tumour microenvironment by cathepsin B, expressed and secreted by the PDAC cell lines tested here, and forms smaller particles that can, in theory, diffuse more efficiently throughout a tumour mass upon extravasation to reach poorly vascularized areas, and improve the efficacy of SDT.